World's Best Scientists 2026 revealed!
Ulrich Specks

Ulrich Specks

D-Index & Metrics

Medicine

D-Index
90
Citations
41404
World Ranking
12011
National Ranking
6156

Overview

Ulrich Specks is affiliated with the Mayo Clinic in the United States and has an extensive publication record in the field of medicine, with a focus on pulmonary and respiratory medicine, rheumatology, genetics, surgery, and physiology. Their research primarily addresses vasculitis and related conditions, coagulation and angioedema, otitis media and relapsing polychondritis, sarcoidosis and beryllium toxicity, renal diseases and glomerulopathies, eosinophilic disorders and syndromes, as well as heparin-induced thrombocytopenia and thrombosis.

Throughout their career, Specks has contributed to numerous papers, including notable works such as:

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, 2020, published in UNC Libraries
  • ANCA-associated vasculitis, 2020, published in Nature Reviews Disease Primers
  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis, 2020, published in New England Journal of Medicine
  • Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis, 2020, published in Annals of the Rheumatic Diseases
  • 2020 international consensus on ANCA testing beyond systemic vasculitis, 2020, published in Autoimmunity Reviews

Frequent co-authors in Specks' work include Fernando C. Fervenza, Peter A. Merkel, Marta Casal Moura, Carol A. Langford, and Sanjeev Sethi.

Specks' research has been disseminated across several prominent publication venues, with notable outputs in:

  • Annals of the Rheumatic Diseases (13 publications)
  • Journal of the American Society of Nephrology (12 publications)
  • Lara D. Veeken (7 publications)
  • Arthritis & Rheumatology (6 publications)
  • CHEST Journal (6 publications)

Their scientific inquiries span critical areas within medicine, with a significant body of work in vasculitis and related immune-mediated conditions. The integration of knowledge across respiratory, rheumatologic, genetic, and physiological domains reflects a multidisciplinary approach to complex diseases and treatment strategies.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo

  • Revised international Chapel Hill consensus conference nomenclature of vasculitides

    J. C. Jennette;R. J. Falk;P. Bacon;N Basu

  • Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

    Michael E. Wechsler;Praveen Akuthota;David Jayne;Paneez Khoury

  • Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

    Ronald J. Falk;Wolfgang L. Gross;Loïc Guillevin;Gary S. Hoffman

  • Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

    Bernhard Nolle;Ulrich Specks;Jens Lüdemann;Michael S. Rohrbach

  • Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis

    Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera

  • ANCA-associated vasculitis.

    A. Richard Kitching;Hans Joachim Anders;Neil Basu;Elisabeth Brouwer

  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

    Michael Walsh;Peter A Merkel;Chen-Au Peh;Wladimir M Szpirt

  • Antineutrophil cytoplasmic antibodies

    Gary S. Hoffman;Ulrich Specks

  • Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.

    Karina A. Keogh;Mark E. Wylam;John H. Stone;Ulrich Specks

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

    Matthieu Groh;Christian Pagnoux;Chiara Baldini;Elisabeth Bel

  • A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    John H. Stone;Gary S. Hoffman;Peter A. Merkel;Yuan I. Min

  • Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial

    Karina A. Keogh;Steven R. Ytterberg;Fernando C. Fervenza;Kimberly A. Carlson

  • Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

    Xavier Bossuyt;Jan Willem Cohen Tervaert;Yoshihiro Arimura;Daniel Blockmans

  • Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis

    James P. Utz;Andrew H. Limper;Sanjay Kalra;Ulrich Specks

  • Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

    Ulrich Specks;Fernando C. Fervenza;Thomas J. McDonald;Marie C. E. Hogan

  • ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.

    Javier D. Finkielman;Augustine S. Lee;Amber M. Hummel;Margaret A. Viss

  • Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists

    Karina A Keogh;Ulrich Specks

  • Brief communication: High incidence of venous thrombotic events among patients with Wegener granulomatosis - The Wegener's clinical occurrence of thrombosis (WeCLOT) study

    Peter A. Merkel;Grace H. Lo;Janet T. Holbrook;Andrea K. Tibbs

Frequent Co-Authors

Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
John H. Stone
John H. Stone Harvard University
E. William St. Clair
E. William St. Clair Duke University
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Alfred Mahr
Alfred Mahr Université Paris Cité
David Jayne
David Jayne University of Cambridge
Raashid Luqmani
Raashid Luqmani University of Oxford
Larry W. Moreland
Larry W. Moreland University of Colorado Anschutz Medical Campus
Eric L. Matteson
Eric L. Matteson Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several online degree options and career pathways worth exploring. Many students look for flexibility and diverse healthcare roles beyond traditional medicine.

For those interested in hospital management or leadership, earning a best online healthcare administration degree can open doors in administration, policy, and healthcare systems. Similarly, professionals already working as registered nurses may pursue a career as a nurse practitioner via an rn to np bridge program, which provides advanced clinical training and expanded patient care responsibilities.

Another growing field is nutrition. With a rising focus on wellness, you can make a difference by completing an online nutrition degree, preparing you for roles in health education, consulting, and dietary planning.

For those aiming high in healthcare leadership, consider top online mha programs that are cahme accredited. These programs are recognized for meeting rigorous standards and can help you stand out in hospital management or executive roles.

Best Scientists Citing Ulrich Specks

Trending Scientists